AC
RNAM

Athos Capital’s Avidity Biosciences RNAM Stock Holding History

Athos Capital’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-184,564
Closed -$13.3M – 49
2025
Q4 		$13.3M Buy
+184,564
New +$11.9M 5.1% 4

Other funds holding RNAM

CC
Corsicana & Co Corsicana, Texas $158M AUM

Athos Capital's RNAM Position: Q1 2026 in Review

Athos Capital sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 184,564 shares — an estimated $13.3M sold.

Athos Capital first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $13.3M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • Athos Capital reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • Athos Capital sold 184,564 Avidity Biosciences shares in Q1 2026, an estimated $13.3M.
  • Athos Capital first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
  • Athos Capital's Avidity Biosciences position peaked at $13.3M in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Athos Capital's 13F filing for Q1 2026, filed 13 May 2026.